Actively Recruiting
Development of Motility and Cognition in Infants
Led by Helsinki University Central Hospital · Updated on 2025-04-03
250
Participants Needed
1
Research Sites
325 weeks
Total Duration
On this page
Sponsors
H
Helsinki University Central Hospital
Lead Sponsor
U
University of Helsinki
Collaborating Sponsor
AI-Summary
What this Trial Is About
PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.
CONDITIONS
Official Title
Development of Motility and Cognition in Infants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age at enrollment 5 to 8 months
- Typically developing infants
You will not qualify if you...
- Any neurologically significant medical history during pregnancy, birth, or postnatally
- Suspicion of developmental delay
- Suspicion or diagnosis of syndromes with neuromotor symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BABA, Clinical Trial Unit, New Children's Hospital
Helsinki, Finland
Actively Recruiting
Research Team
S
Sampsa Vanhatalo, prof
CONTACT
L
Leena Haataja, prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here